PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 2019Translational Lung Cancer Research392 citationsOpen Access

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

HMHiren MandaliyaMJMark JonesCOChristopher Oldmeadow

Key Points

Key points are not available for this paper at this time.

Abstract

High NLR, high PLR, low LMR and low ALI at baseline are significantly associated with poor OS. High NLR and low ALI are significantly associated with poor OS post treatment. Findings are similar regardless of age.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mandaliya et al. (2019) studied this question.

synapsesocial.com/papers/69df19c3d5404a0bea591ef8https://doi.org/10.21037/tlcr.2019.11.16
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet2014 · 67 citations
  2. 2Greater risks of chemotherapy toxicity in elderly patients with cancer.2004 · 206 citations
  3. 3Cancer statistics, 20192019 · 21,028 citations
  4. 4Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 20122013 · 35 citations
  5. 5Geriatric oncology: problems with under-treatment within this population.2015 · 53 citations